
Bioorganic and Medicinal Chemistry Letters p. 473 - 476 (1998)
Update date:2022-08-04
Topics:
Zimmerman, Dennis M.
Cantrell, Buddy E.
Smith, Edward C.R.
Nixon, James A.
Bruns, Robert F.
Gitter, Bruce
Hipskind, Philip A.
Ornstein, Paul L.
Zarrinmayeh, Hamideh
Britton, Thomas C.
Schober, Douglas A.
Gehlert, Donald R.
The characterization of a novel series of NPY-1 receptor antagonists derived from the 4-methylbenzimidazole 4 is described. Appropriate substitution on the piperidyl nitrogen of 4 led to systematic increases in Y-1 receptor affinity, to approximately 50-fold, and to the discovery of the importance of a second basic substituent.
View Morewebsite:http://www.arromax.com
Contact:+86-0512-62959601 skype:aimmezhang
Address:Suite 401, Bldg A3, 218 Xinghu St.Suzhou Industrial Park 215123, P.R. China
ANHUI CHEM-BRIGHT BIOENGINEERING CO.,LTD
Contact:86-561-4080321
Address:No.8 Lieshan Industrial Zone of Huaibei
Xuzhou Tianrun Chemical Co.,Ltd
website:http://www.tianrunchem.cn
Contact:86-516-83832636
Address:fuxing road
Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd
website:http://www.jlpharms.com
Contact:86-571-86982636
Address:Rm A606, Fuyi Center, jianqiao street
Xi'an Kaixiang Photoelectric Technology Co., Ltd
website:http://www.kxmaterials.com/
Contact:86-29-15991651477
Address:Building 6, Biopharmaceutical Industry R&D Cluster Base, No. 16, Caotang 4th Road, Caotang Science and Technology Industrial Base, High-tech Zone, Xi'an City, Shaanxi Province, China
Doi:10.1002/asia.201801454
(2018)Doi:10.1246/bcsj.34.1846
(1961)Doi:10.1002/jhet.5570350235
(1998)Doi:10.1134/S1070363219040169
(2019)Doi:10.1021/jo9803434
(1998)Doi:10.1016/S0040-4039(01)00101-0
(2001)